University of Nebraska Medical Center

Alzheimer’s Disease & Related Dementia Drug Discovery Training Program

Woman sits in front of computer screen that has an MRI scan of a brain with Alzheimer's.

Be at the forefront of discovering new treatments to improve the well-being of the 6.9 million Americans who have Alzheimer's Disease.

With the number of individuals diagnosed with Alzheimer’s disease and related dementias expected to keep rising, UNMC is preparing the next generation of scientists and clinicians to drive Alzheimer’s Disease and drug development research forward.

The UNMC Training Program in Alzheimer’s Disease and Related Dementia Drug Discovery tackles the complexities presented by these dementias, enabling us to create groundbreaking discoveries that help doctors understand and treat Alzheimer's.

If you are accepted into the program, you will have the opportunity to conduct hands-on research to identify new targets, new models and new drugs for the potential treatment of Alzheimer's disease and related dementias. Plus, you'll receive training from renowned faculty from an array of disciplines who care for individuals with Alzheimer's disease and related dementias — so you can see potential areas where your research can improve human health. 

This is an NIH-funded T32 program administered jointly by the Department of Pharmaceutical Sciences and Department of Neurological Sciences at UNMC.


Associate Professor, College of Pharmacy
Director, Pharmaceutical Sciences Graduate Program


Lab website

Professor, Department of Neurological Sciences
Senior Associate Dean of Research & Development, College of Medicine

Lab website